Publications by authors named "William Pullman"

Claim this Profile
P
Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial.
Tze-Chiang Meng, Jerzy P Szaflarski, Linda Chen, Marcus Brunnert, Rita Campos, William E Pullman

Epilepsy Behav· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: A double-blind, randomized, placebo-controlled trial.
David C Spencer, Saurabh R Sinha, Eun Jung Choi, Jody M Cleveland, Aliceson King, William E Pullman

Epilepsia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.
Kamil Detyniecki, Peter J Van Ess, David J Sequeira, James W Wheless, Tze-Chiang Meng, William E Pullman

Epilepsia· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: An open-label extension trial.
James W Wheless, Tze-Chiang Meng, Peter J Van Ess, Kamil Detyniecki, David J Sequeira, William E Pullman

Epilepsia· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.
William R Lumry, Jonathan A Bernstein, H Henry Li, Andrew J MacGinnitie, Marc Riedl, William E Pullman

Allergy Asthma Proc· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
Albert L Sheffer, Andrew J MacGinnitie, Marilyn Campion, Leslie E Stolz, William E Pullman

Ann Allergy Asthma Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.
Andrew J MacGinnitie, Marilyn Campion, Leslie E Stolz, William E Pullman

Allergy Asthma Proc· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.
Albert L Sheffer, Marilyn Campion, Robyn J Levy, H Henry Li, Patrick T Horn, William E Pullman

J Allergy Clin Immunol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to response outcomes in hereditary angioedema.
William Pullman

Ann Allergy Asthma Immunol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response time for ecallantide treatment of acute hereditary angioedema attacks.
Marc Riedl, Marilyn Campion, Patrick T Horn, William E Pullman

Ann Allergy Asthma Immunol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecallantide for the treatment of acute attacks in hereditary angioedema.
Marco Cicardi, Robyn J Levy, Donald L McNeil, H Henry Li, Albert L Sheffer, William E Pullman

N Engl J Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema.
Robyn J Levy, William R Lumry, Donald L McNeil, H Henry Li, Marilyn Campion, William E Pullman

Ann Allergy Asthma Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic costs associated with acute attacks and long-term management of hereditary angioedema.
David A Wilson, Konrad Bork, Elizabeth P Shea, Anne M Rentz, Marc B Blaustein, William E Pullman

Ann Allergy Asthma Immunol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From bench to clinic and back: Perspective on the 1st IQPC Translational Research conference.
Heidi Hörig, William Pullman

J Transl Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study.
Raymond C Rosen, Harin Padma-Nathan, Ridwan Shabsigh, Khalil Saikali, Vish Watkins, William Pullman

J Sex Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis